Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
heptasodium 6,7,15,16,24,25,33,34-octakis(3-carboxy-5-carboxylatophenoxy)-2,11,20,29,38,39,40,41-octaaza-1-zincadodecacyclo[19.17.1.1^{1,12}.1^{3,37}.0^{2,10}.0^{4,9}.0^{13,18}.0^{22,27}.0^{28,39}.0^{30,38}.0^{31,36}.0^{19,41}]hentetraconta-2,4(9),5,7,10,12,14,16,18,20,22(27),23,25,28(39),29,31(36),32,34,37(40)-nonadecaene-2,39-bis(ylium) sodium
ID: ALA2146080
PubChem CID: 71454594
Max Phase: Preclinical
Molecular Formula: C96H39N8Na9O40Zn
Molecular Weight: 1955.47
Molecule Type: Small molecule
Associated Items: